IVIAT: a novel method to identify microbial genes expressed specifically during human infections.
about
Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patientsInformation overload: assigning genetic functionality in the age of genomics and large-scale screeningNovel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesisIdentification of in vivo induced protein antigens of Salmonella enterica serovar Typhi during human infection.Host-inducible immunogenic sphingomyelinase-like protein, Lk73.5, of Leptospira interrogans.Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio choleraeUse of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.Identification of a novel adhesion molecule involved in the virulence of Legionella pneumophila.Genes of periodontopathogens expressed during human disease.Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis.Use of in vivo-induced antigen technology (IVIAT) for the identification of Streptococcus suis serotype 2 in vivo-induced bacterial protein antigens.Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT).Gene expression in Porphyromonas gingivalis after contact with human epithelial cells.Identification of group A Streptococcus antigenic determinants upregulated in vivo.Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Identification of Escherichia coli genes that are specifically expressed in a murine model of septicemic infectionA comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening.Proteomics-based expression library screening - a platform technology for rapid discovery of pathogen-specific markers of infection.Use of in vivo induced antigen technology to identify genes from Aeromonas salmonicida subsp. salmonicida that are specifically expressed during infection of the rainbow trout Oncorhynchus mykiss.Virulence as a target for antimicrobial chemotherapy.Identification of Salmonella enterica serovar Pullorum antigenic determinants expressed in vivo.A member of the peptidase M48 superfamily of Porphyromonas gingivalis is associated with virulence in vitro and in vivo.Identification of genes expressed during Toxoplasma gondii infection by in vivo-induced antigen technology (IVIAT) with positive porcine sera.Genomics of oral bacteria.Molecular genetic analysis of the virulence of oral bacterial pathogens: an historical perspective.Identification of Enterococcus faecalis antigens specifically expressed in vivo.Postgenomic approaches to cholera vaccine development.Measuring Escherichia coli Gene Expression during Human Urinary Tract InfectionsIdentification and real-time expression analysis of selected Toxoplasma gondii in-vivo induced antigens recognized by IgG and IgM in sera of acute toxoplasmosis patients.Antigens of Aeromonas salmonicida subsp. salmonicida specifically induced in vivo in Oncorhynchus mykiss.Immunoprotective Efficacy of Six In vivo-Induced Antigens against Actinobacillus pleuropneumoniae as Potential Vaccine Candidates in Murine ModelDistinct transcriptional profiles characterize oral epithelium-microbiota interactions.In-vivo-induced antigenic determinants of Fusobacterium nucleatum subsp. nucleatum.Analysis of a band 7/MEC-2 family gene of Porphyromonas gingivalis.Characterization and reactivity of broiler chicken sera to selected recombinant Campylobacter jejuni chemotactic proteins.Identification of Riemerella anatipestifer genes differentially expressed in infected duck livers by the selective capture of transcribed sequences technique.Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.A new age in AquaMedicine: unconventional approach in studying aquatic diseases.Oral bacterial disease and the science of cellular conversation.Effective Pro-Inflammatory Induced Activity of GALT, a Conserved Antigen in , Improves the Cytokines Secretion of Macrophage via p38, ERK1/2 and JNK MAPKs Signal Pathway
P2860
Q24564924-8C125C72-DDC8-43B0-955A-E81929651A12Q28763901-FF057EF1-3853-4B72-9C64-14EF120FAC55Q30802772-516D9B0B-47C7-4971-A5B9-9C0945B75E8DQ30884352-07AD01F6-ABA8-43E9-9F8E-22D9BCC03F13Q31037865-9CBE7BD2-5B2B-4568-921D-5DB351FDD875Q31147722-6A99BC3E-7048-4991-BA70-68B8B9A68AB9Q33214290-015A49A7-BCC5-4FB8-83CD-E4DAFBD57D83Q33217675-5F022447-8D92-470A-ABD0-2C43ABA3EC0AQ33218826-CF5165E2-5F09-4AAD-ACEB-2D0ED4B60FEFQ33324401-AAFC926A-5861-4BAD-BA9C-B75E5A187C2EQ33504857-497001DE-8F5E-4992-A8EC-1FA197C82849Q33722105-14277FFD-86C1-490F-A52B-E96C5CAB764AQ33769338-C1E7E81D-AB20-4F84-A12D-42DCAEB12169Q34034212-B43D3FD5-FD8B-4F24-9CCF-7D9A74AA3338Q34113328-F800E72E-9C73-42AE-A4BA-D2E2B02F260CQ34127061-45548F53-8CDE-42A8-9740-BCD0C4B3D07AQ34181546-75D49346-453A-4489-9EC9-FC993CDA87B2Q34621262-BC8B1FC4-8A93-4631-95A2-4D586D515B52Q34728817-CDE0600A-EA7E-40D7-9DEA-AA44171C4863Q34768578-53932276-1548-4397-9335-9709F13C7E1EQ34775184-BB634513-856C-47AA-BF4B-AE623A18E9DDQ34795787-A3E0EE3C-A7BF-42F4-ADEB-0A77534CA99FQ35124741-DF761828-0D83-448C-AB52-4572777E6493Q35150809-DA9E3405-F63C-4BF4-BA64-CDA317636EECQ35552587-62BE3AEE-6A98-4198-A257-DD52F2A8E149Q36293229-4EA2DFAB-7826-45DC-8B30-13A7C6CA6969Q36530216-F17251E3-8BC0-42F4-8761-37E9DE19AA34Q36735393-83714A30-5CF5-454D-93D9-6656AAF1A6A9Q36964387-4736FAB3-AC52-40CB-BF84-60C0705F9A0AQ37107123-824A739A-0BBE-4FE8-98F3-07DCB4CBA695Q37356033-94B29C99-51DC-4F80-8086-2A04891E3BE0Q38520459-571C6F33-EC2D-427E-964F-5FDE920928EFQ39581255-9E802B70-ED0E-4629-8667-77C6E681804AQ41589711-C606357A-81F3-40AB-A515-7EDC2384411CQ54293569-92781F1C-6DFA-4651-B080-E186B2915702Q54453163-95739247-8B34-44BC-8040-5C7A7187628CQ55173091-C6ED5173-D709-4EBF-8287-B16D9CCCD506Q55415886-86F7F741-2DCD-43F0-A619-6234A6FBFAC7Q55453872-D238D12E-E73F-4AE2-9F34-F857E5B5435CQ57491945-5E806E3C-4BEA-42FF-A88F-9B10D52D6EB7
P2860
IVIAT: a novel method to identify microbial genes expressed specifically during human infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
IVIAT: a novel method to ident ...... cally during human infections.
@ast
IVIAT: a novel method to ident ...... cally during human infections.
@en
type
label
IVIAT: a novel method to ident ...... cally during human infections.
@ast
IVIAT: a novel method to ident ...... cally during human infections.
@en
prefLabel
IVIAT: a novel method to ident ...... cally during human infections.
@ast
IVIAT: a novel method to ident ...... cally during human infections.
@en
P2093
P1476
IVIAT: a novel method to ident ...... cally during human infections.
@en
P2093
Handfield M
Hillman JD
Progulske-Fox A
P304
P356
10.1016/S0966-842X(00)01775-3
P577
2000-07-01T00:00:00Z